Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 6
2018 3
2019 2
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Cited In for PMID: 26998514

13 results
Results by year
Filters applied: . Clear all
Page 1
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?
Amata E, Xi H, Colmenarejo G, Gonzalez-Diaz R, Cordon-Obras C, Berlanga M, Manzano P, Erath J, Roncal NE, Lee PJ, Leed SE, Rodriguez A, Sciotti RJ, Navarro M, Pollastri MP. Amata E, et al. ACS Infect Dis. 2016 Mar 11;2(3):180-186. doi: 10.1021/acsinfecdis.5b00136. Epub 2016 Jan 17. ACS Infect Dis. 2016. PMID: 26998514 Free PMC article.
Emerging therapeutic targets for treatment of leishmaniasis.
Sundar S, Singh B. Sundar S, et al. Expert Opin Ther Targets. 2018 Jun;22(6):467-486. doi: 10.1080/14728222.2018.1472241. Epub 2018 May 9. Expert Opin Ther Targets. 2018. PMID: 29718739 Free PMC article. Review.
Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma.
Longhitano L, Castracani CC, Tibullo D, Avola R, Viola M, Russo G, Prezzavento O, Marrazzo A, Amata E, Reibaldi M, Longo A, Russo A, Parrinello NL, Volti GL. Longhitano L, et al. Oncotarget. 2017 Jul 25;8(53):91099-91111. doi: 10.18632/oncotarget.19556. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207628 Free PMC article.
13 results